BioCentury
ARTICLE | Clinical News

Pulmonary delivery of dry powder insulin: Partner Pfizer Inc. began Phase III testing.

November 16, 1998 8:00 AM UTC

Inhale Therapeutic Systems Inc. (INHL), San Carlos, Calif. Product: Pulmonary delivery of dry powder insulin Indication: Treat Types I and II diabetes Status: Partner Pfizer Inc. began Phase III test...